Loading...
|
Please use this identifier to cite or link to this item:
https://nccur.lib.nccu.edu.tw/handle/140.119/30215
|
| Title: | 生技產業無形資產之揭露與資訊內涵 |
| Authors: | 黃于庭 |
| Contributors: | 蘇瓜藤
黃于庭 |
| Keywords: | 無形資產
揭露品質
生技公司 |
| Date: | 2007 |
| Issue Date: | 2009-09-11 17:28:13 (UTC+8) |
| Abstract: | 無形資產係生技公司的核心競爭力來源。由於其無形資產之高度知識密集性，投資人必須仰賴公司所揭露的資訊，方能有效評估生技公司之核心競爭力。因此無形資產之揭露品質，對投資人評估生技公司而言，扮演著關鍵的角色。
<br>本研究旨在探討生技公司之無形資產揭露品質。首先，本研究檢視三十六家生技公司在其民國九十六年度年報及網站上有關無形資產之揭露，並以二十三個指標評分其揭露品質。其次，本研究採用迴歸模型及無母數統計方法，分析該揭露品質與股票週轉率及報酬之關係。最後，本研究分析影響該揭露品質之公司特性。<br>實證結果顯示，生技公司之無形資產揭露品質偏低，100 分中僅得到平均31.10 分。迴歸及無母數統計結果顯示，生技公司之無形資產揭露品質與其股票週轉率及報酬之關係，皆未達顯著水準。公司特性中僅有研究發展費用佔營業收入淨額比率，與揭露品質之關係達到顯著水準，顯示生技公司研發活動會影響其無形資產揭露品質。
Intangible assets of a biotechnology company are its major source of core competitiveness. Due to the high level of knowledge intensiveness of intangible assets, investors rely heavily on the disclosed information pertaining to such assets for effective evaluation of its core competitiveness. The disclosure quality therefore plays a key role in such evaluation.<br>This research aims to explore the disclosure quality of biotechnology companies pertaining to intangible assets. The sample consists of 36 biotechnology companies and 23 measures are used to rate the disclosure quality on their 2007 annual reports and websites. Next, the associations of such disclosure quality and the stock trading volume and return are analyzed, using regression models and nonparametric tests. Finally, company characteristics affecting such disclosure quality are analyzed<br>The empirical results indicate that biotechnology companies do not score well in disclosure quality pertaining to intangible assets, with an average of 31.10 out of 100 points. Statistically, such disclosure quality is not associated with the trading volume or return of their stocks. The ratio of research and development expense to net sales is significantly associated with the disclosure quality, suggesting that research and development activities of biotechnology companies affect their disclosure quality pertaining to intangible assets. |
| Reference: | 田蔚城，1997，生物技術的發展與應用，台北：九州圖書文物公司出版。
行政院國科會生物技術產業小組，2002，2002 生技產業白皮書，台北：經濟部工業局出版。
牟敦剛，1996，推動我國生物技術及相關產業升級之課題探討，經濟情勢評論季刊第2卷第1期(5月)： 76-93。
余駿展，2007，資產減損會計揭露準則之實證硏究，國立政治大學會計系未出版碩士論文。
林勝結，2002，無形資產與企業價值關係之研究，國立中正大學企管系未出版碩士論文。
邱碧珠，2000，資訊揭露程度與權益資金成本間之關係：我國資訊電子業之研究，國立臺灣大學會計系未出版碩士論文。
莊尚志，2003，資訊揭露程度與資金成本關係之實證研究，私立東吳大學會計系未出版碩士論文。
財團法人生物技術開發中心，2003，生物技術產業年鑑2003，台北：財團法人生物技術開發中心出版。
張窈菱，2004，年報揭露程度與分析師盈餘預測關係之研究，國立政治大學會計系未出版碩士論文。
張婷婷，2002，財務報表攸關性之探討-未入帳無形價值因素之考量，私立中原大學會計系未出版碩士論文。
張毓芳，2003，無形資產之價值攸關性，國立政治大學會計系未出版碩士論文。
經濟部工業局，1999，生物技術工業發展策略與措施，台北：經濟部工業局出版。
經濟部生物技術與醫療工業發展推動小組，2007，中華民國生物技術與製藥工業簡介，台北：經濟部工業局出版。
蔡其諭，2001，揭露程度與負債資金成本之關係，國立政治大學會計系未出版碩士論文。
Barry, C. B., and S. J. Brown. 1985. Differential information and security market equilibrium. Journal of Financial and Quantitative Analysis 20 (December): 407-422.
Barth, M. E., and R. Kasznik. 1999. Share repurchases and intangible assets. Journal of Accounting and Economics 28 (December): 211-241.
Bawa, V. S., and R. W. Klein. 1976. The effect of estimation risk on optimal portfolio choice. Journal of Financial Economics 3 (June): 215-331.
Beaver, W. H. 1968. The information content of annual earning announcements. Journal of Accounting Research 6: 67-92.
Biotechnology Research Subcommittee. 1995. Biotechnology For The 21st Century: New Horizons. Washington: National Science and Technology Council.
Bloomfield, R. J., and T. J. Wilks. 2000. Disclosure effects in the laboratory: Liquidity, depth, and the cost of capital. The Accounting Review 75 (January): 13-41.
Bosworth, D., and M. Rogers. 2001. Market value, r&d and intellectual property: An empirical analysis of large Australian firms. The Economic Record 77 (December):323-337.
Botosan, C. A. 1997. Disclosure level and the cost of equity capital. The Accounting Review 72 (July): 323-349.
Bozzolan, S., F. Favotto, and F. Ricceri. 2003. Italian annual intellectual capital disclosure: An empirical analysis. Journal of Intellectual Capital 4 (4): 543-558.
Bradley, K. 1997. Intellectual capital and the new wealth of nations. Business Strategy Review 8 (Spring): 53-62.
Bukh, P. N., C. Nielsen, P. Gormsen, and J. Mouritsen. 2005. Disclosure of information on intellectual capital in Danish IPO prospectuses. Accounting, Auditing & Accountability Journal 18 (6):713-732.
Chauvin, K.W., and M. Hirschey. 1993. Advertising, r&d expenditures and the market value of the firm. Financial Management 22 (Winter): 128-140.
Collins, D. W., E. L. Maydew, and I. S. Weiss. 1997. Changes in the value relevance of earnings and book values over the past forty years. Journal of Accounting and Economics 24 (December): 39-67.
Cooke, T. E. 1989. Disclosure in the corporate annual reports of Swedish companies. Accounting and Business Research 19 (Spring): 113-124.
Diamond, D. W., and R. E. Verrecchia. 1991. Disclosure, liquidity and the cost of capital. Journal of Finance 46 (September): 1325-1359.
Elliott, R. K., and P. D. Jacobxon. 1994. Cost and benefits of business information disclosure. Accounting Horizons (December): 80-96.
Ely, K., and G. Waymire. 1999. Intangible assets and stock prices in the pre-SEC era. Journal of Accounting Research 37 (Supplement):17-44.
Ettredge, M., V. J. Richardson, and S. Scholz. 2001. The presentation of financial information at corporate web sites. International Journal of Accounting Information Systems 2 (September): 149-168.
García-Meca, E., and I. Martínez. 2005. Assessing the quality of disclosure on intangible in Spanish capital market. European Business Review 17 (4): 305-313.
García-Meca, E., I. Parra Frutos, and I. Martínez Conesa. 2001. Information disclosure indexes to quantify complex categorical variables: A study of intellectual capital. Working paper. Universidad de Murcia.
Glick, J. L. 1999. Experimental support for a biotechnology investment strategy. Technology Management: Strategic＆ Applications 5 (2): 111-118.
Gray, S. J., and C. B. Robert. 1989. Voluntary information disclosure and the British multinationals: Corporate perceptions of costs and benefits, in Hopwood, A (ed.) International Pressures for Accounting Change. Hemel Hempstead: Pretice-hall, 116-139.
Gu, F., and B. Lev. 2001. Intangible assets, measurement, drivers, usefulness. Working paper. Boston University and New York University.
Guo, Re-Jin, B. Lev, and N. Zhou. 2004. Competitive costs of disclosure by biotech IPOs. Journal of Accounting Research 42 (May): 319-355.
Healy, P. M., A. P. Hutton, and K. G. Palepu. 1999. Stock performance and intermediation changes surrounding sustained increases in disclosure. Contemporary Accounting Research 16 (Fall): 485-520.
Healy, P. M., and K. G. Palepu. 1993. The effect of firms’ financial disclosure strategies on stock prices. Accounting Horizons 7 (March): 1-11.
Healy, P. M., and K. G. Palepu. 2001. Information asymmetry, corporate disclosure, and the capital market: A review of the empirical literature. Journal of Accounting and Economics 31 (September): 405-440.
Hooks, J., D. Coy, and H. Davey. 2002. The information gap in annual reports. Accounting, Auditing& Accountability Journal 15 (4): 501-522.
Kim, M., and J. R. Ritter. 1999. Valuing IPOs. Journal of Financial Economics 53 (September): 409-437.
Lang, M. H., and R. J. Lundholm. 1996. Corporate disclosure policy and analyst behavior. The Accounting Review 71 (October): 467-492.
Leitner, Karl-Heinz. 2005. Managing and reporting intangible assets in research technology organisations. R&D Management 35 (March): 125-136.
Lev, B. 1988. Toward a theory of equitable and efficient accounting policy. The Accounting Review 63 (January): 1-22.
Lev, B., and P. Zarowin. 1999. The boundaries of financial reporting and how to extend them. Journal of Accounting Research 37 (Autumn): 353-389.
Lodise, C. 1990. Biotechonlogy: Is the M&A rush finally on. Corporate Growth Report 8 (3): 8-11.
Marston, C. L., and P. J. Shrives. 1991. The use of disclosure indices in accounting research: A review article . British Accounting Review 23 (March):195-210.
Meek, G. K., C. B. Roberts, and S. J. Gray. 1995. Factors influencing voluntary annual report disclosures by U.S., U.K. and continental European multinational corporations. Journal of International Business Studies 26(3): 555-572.
OECD. 2005. A Framework For Biotechnology Statistics. Paris: OECD.
Ritter, A., and P. Wells. 2006. Identifiable intangible asset disclosures, stock prices and future earnings. Accounting and Finance 46 (December): 843-863.
Roberts, E. B., and R. Mizouchi. 1989. Inter-firm technological collaboration: The case of Japanese biotechnology. International Journal of Technology Management 4 (1):43-61.
Spalding, B. J. 1986. How biotechnology is farming as a Industry. Chemical Week 139 (23): 9-13.
Spero, L. L. 1979. The extent and causes of voluntary disclosure of financial information in three European capital markets: An exploratory study. Working paper. Harvard University.
Tasker, S. 1998. Bridging the information gap: Quarterly conference calls as a medium for voluntary disclosure. Review of Accounting Studies 3 (March): 137-167.
Wyatt, A. 2005. Accounting recognition of intangible assets: theory and evidence on economic determinants. The Accounting Review 80 (July): 967-1003. |
| Description: | 碩士
國立政治大學
會計研究所
95353015
96 |
| Source URI: | http://thesis.lib.nccu.edu.tw/record/#G0095353015 |
| Data Type: | thesis |
| Appears in Collections: | [會計學系] 學位論文
|
Files in This Item:
| File |
Size | Format | |
|---|
| index.html | 0Kb | HTML2 | 195 | View/Open |
|
All items in 政大典藏 are protected by copyright, with all rights reserved.
|
